FOI release

Request for clinical overivew of Nizatidine

Some or all of the information requested may not have been provided because we required clarification from the requester.

Case reference FOI2025/01120

Received 24 October 2025

Published 4 December 2025

Request

Please note that we are in development phase for Nizatidine 150mg & 300mg Capsule and wish to file a National application in UK (UK wide). Our kind request to agency to provide clinical overview Nizatidine Capsule.

Response

See attached

Documents

• FOI2025_01120 (redacted).pdf (548.6 KB)

This is Medicines and Healthcare products Regulatory Agency's response to a freedom of information (FOI) or environmental information regulations (EIR) request.

You can browse our other responses or make a new FOI request.